EC Number | Inhibitors | Comment | Organism | Structure |
---|---|---|---|---|
2.4.2.26 | heparin | non-competitive inhibitor using fragment(1-24) of human basic fibroblast growth factor as xylose acceptor | Homo sapiens |
EC Number | KM Value [mM] | KM Value Maximum [mM] | Substrate | Comment | Organism | Structure |
---|---|---|---|---|---|---|
2.4.2.26 | 0.0208 | - |
fragment(1-24) of human basic fibroblast growth factor | native XT-I | Homo sapiens | |
2.4.2.26 | 0.0223 | - |
fragment(1-24) of human basic fibroblast growth factor | recombinant XT-I | Homo sapiens | |
2.4.2.26 | 0.0572 | - |
human basic fibroblast growth factor | native XT-I | Homo sapiens |
EC Number | Localization | Comment | Organism | GeneOntology No. | Textmining |
---|---|---|---|---|---|
2.4.2.26 | extracellular | - |
Homo sapiens | - |
- |
EC Number | Organism | UniProt | Comment | Textmining |
---|---|---|---|---|
2.4.2.26 | Homo sapiens | - |
- |
- |
EC Number | Source Tissue | Comment | Organism | Textmining |
---|---|---|---|---|
2.4.2.26 | blood serum | patients with osteoarthritis | Homo sapiens | - |
2.4.2.26 | culture supernatant | of JAR choriocarcinoma cells secrete six times more XT-I than the osteogenic sarcoma cell line SAOS-2 and 40times more XT-I than the fibroblast cell line hTERT-BJ1 | Homo sapiens | - |
EC Number | Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|---|
2.4.2.26 | UDP + fragment(1-24) of human basic fibroblast growth factor | - |
Homo sapiens | UDP + ? | - |
? | |
2.4.2.26 | UDP + human basic fibroblast growth factor | transfer of xylose to the serine residue of the G-S-G-motif in the amino terminal end of human basic fibroblast growth factor | Homo sapiens | UDP + ? | - |
? | |
2.4.2.26 | UDP-D-xylose + bikunin | - |
Homo sapiens | UDP + D-xylosyl-bikunin | - |
? |
EC Number | Synonyms | Comment | Organism |
---|---|---|---|
2.4.2.26 | XT-I | - |
Homo sapiens |